Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold... see more

CSE:SONA - Post Discussion

Sona Nanotech Inc > SONA in Journal of Experimental Biology and Agricultural
View:
Post by wintrader on Oct 09, 2020 8:53am

SONA in Journal of Experimental Biology and Agricultural

This was written in the Journal :    Have a look !!!  Another evidence it's coming ...

Similarly the study also suggest, Sona Nanotech (Halfax, Canada) in collaboration with GE Health Life Sciences has been working on the S protein (S1 domain) of the virus in developing a rapid immunoassay that could detect antigens of SARS-CoV-2 in about 5-15 minutes and (Lee et al., 2020). The recent study done by Carter et al., 2020 suggest that Canada has approved Rapid SARS-CoV-2 antigen detection test developed by Nova Scotiathat detect S1 domain of S protein in nasal swab. The study also suggest many antigen

file:///C:/Users/Daniel/Downloads/CoronaViruses.pdf
Comment by scarey240 on Oct 09, 2020 9:23am
Please share the link, not your files on your computer
Comment by wintrader on Oct 09, 2020 9:32am
Here is the link :     https://www.researchgate.net/publication/344546729_CORONAVIRUSES_DIAGNOSTIC_APPROACHES_FOR_COVID-19
Sona Nanotech Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested